A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
15 locations incl. La Jolla
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06385080·Phase 1, Phase 2·Recruiting